Crossmark

Co-administration of nobiletin and tetrahydrocurcumin enhanced the cytotoxicity to breast cancer through inhibiting CYP1A1 enzyme: from the perspective of pharmacokinetic interactions

Crossref DOI link: https://doi.org/10.1007/s12672-025-03229-0

Published Online: 2025-08-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Song, Hongming

Gao, Fengqin

Niu, Zhaohe

Liu, Xiangping

Wang, Xingang

Cao, Weihong

Wang, Haibo
License Information

Text and Data Mining valid from 2025-08-04

Version of Record valid from 2025-08-04
More Information

Article History

Received: 18 February 2025

Accepted: 15 July 2025

First Online: 4 August 2025

Declarations

:

: This study had been approved by the Ethics Committee of The Affiliated Hospital of Qingdao University. The study was conducted in agreement with the ARRIVE guidelines.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below